Pheniprazine
| Pheniprazine | |
|---|---|
| Salts [] | |
|---|---|
| Pheniprazine hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 150.22 g/mol [1] |
| Predicted LogP | 1.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H14N2 |
| IUPAC name | 1-phenylpropan-2-ylhydrazine |
| SMILES | CC(CC1=CC=CC=C1)NN |
| InChI | InChI=1S/C9H14N2/c1-8(11-10)7-9-5-3-2-4-6-9/h2-6,8,11H,7,10H2,1H3 |
| InChIKey | VXTWEDPZMSVFEF-UHFFFAOYSA-N |
| CAS number | 55-52-7 |
| UNII | 37VKD7067M |
| PubChem CID | 5929 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Oral |
Pheniprazine (also known as β-Phenylisopropylhydrazine, (1-phenylpropan-2-yl)hydrazine, Hydrazine, (1-methyl-2-phenylethyl)-, Pheniprazine dl-, 200-236-6, Feniprazina, Phenizine, Dicatron, Hydrazine, 1-methyl-2-phenylethyl or Fenilisopropilidrazina) is a monoamine oxidase inhibitor substance of the amphetamine class.
Chemistry
Salts []
Pheniprazine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Pheniprazine is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Pheniprazine matches Lipinski's rule of five.Legal status []
- Brazil: Pheniprazine is a C1.[3]
- Other: Pheniprazine is a Uncontrolled.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5929, Pheniprazine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5929
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Pheniprazine. UNII: 37VKD7067M. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/37VKD7067M
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:36:45 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 08:36:41 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 08:36:40 |
| gsrs | ok | 2026-11-20 08:36:42 |
| hmdb | missing (no HMDB id) | 2026-11-20 08:36:40 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 08:36:44 |
| pubchem | ok | 2026-11-20 08:36:40 |
| missing (no r/tripreports posts mention it) | 2026-11-20 08:36:40 | |
| sider | missing (not in SIDER) | 2026-11-20 08:36:40 |
| structure | ok | 2026-11-20 08:36:40 |
| wikipedia | ok | 2026-11-20 08:36:41 |